ADAR1 Capital Management »

Bolt Biotherapeutics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Bolt Biotherapeutics (BOLT) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Bolt Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bolt Biotherapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bolt Biotherapeutics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.0k 5.0k 1.40

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Bolt Biotherapeutics

Tang Capital Management
Sofinnova Ventures
Pivotal bioVenture Partners Investment Advisor
Nan Fung Group Holdings
Vanguard Group
Samsara BioCapital
Board of Trustees of The Leland Stanford Junior University
Newtyn Management
Geode Capital Management
Renaissance Technologies
BlackRock
BlackRock
Susquehanna International
Bridgeway Capital Management
Two Sigma Securities

View all funds holding Bolt Biotherapeutics